Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors

Published: Friday, February 14, 2014
Last Updated: Friday, February 14, 2014
Bookmark and Share
Presents validation data for improving media screening and process optimization.

TAP Biosystems has announced that it will be co-presenting a new bioprocess webinar with Irvine Scientific, a major producer of cell culture media, on Wednesday March 12th 2014 at 9 am PST / 12 noon EST / 4 pm GMT.

The live event will detail how to use ambr™ automated micro bioreactor system in alternative semi-continuous modes to mimic perfusion cultures and how this can be used to save time with process optimization and media screening.

Bioprocessing experts, Tom Fletcher, R&D Director at Irvine Scientific and Dr Don Traul, Product Specialist at TAP Biosystems, will present technical data on the use of the ambr 10 - 15ml micro bioreactor system, as a small scale perfusion culture mimic.

To access the webinar, scientists can register at: http://www.tapbiosystems.com/ambr_webinar/ambrIrvine_WebinarPR.htm.

During the webinar, Dr Traul will describe how the ambr system has been utilized as a semi-continuous chemostat model, present field data validating the scalability of the ambr system for continuous culture, and discuss associated DoE applications for media development.

Tom Fletcher will be presenting his use of the ambr system in an alternative semi-continuous mode and will describe the productivity benefits of using ambr to screen a range of candidate media formulations.

Dr Don Traul, TAP Biosystems’ ambr Product Specialist commented: "To date there has been a lack of good scale-down models of large-scale perfusion culture, which has prevented the widespread adoption of this technique as a method for increasing protein yields in biologics production.”

Traul added: “Perfusion culture is a good option for production of unstable or minimally expressing proteins or antibodies and I am pleased to be hosting a webinar alongside Tom Fletcher in which we’ll show proof-of-concept data for use of ambr as a scale down perfusion culture mimic. This will demonstrate how ambr may benefit scientists looking for a strategy to save valuable time with media and process development and will provide them with information on how to rapidly scale up an optimum perfusion culture process for improving production of difficult to manufacture biologics.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Inspiring Futuristic Innovation: Brain ‘Organoids’
Scientists create artificial brains, providing an advanced model for studying brain tumour development.
Tissue Damage Is Key for Cell Reprogramming
Researchers have shown tissue damage is important for cells to return to an embryonic state for cell reprogramming.
Making Personalized Medicine a Reality
Groundbreaking technique developed at McMaster University is helping to pave the way for advances in personalized medicine.
Regenerating Diseased Hearts
Researchers from the University of Otago have probed the potential of adult stem cell types to repair diseased hearts.
Using Cancer Cells' Mass to Predict Treatment Response
A device has been developed that can detect changes in cell mass at a minute scale.
Color-Coded Stem Cells
Researchers develop colour-coding tool for tracking live blood stem cells over time.
Human Intestines and Functioning Nerves Engineered
The new technology enables the study of human health and advances the goal of regenerative medicine.
Chemical Snapshots Could Lead to Better Engineered Cartilage
Taking "chemical photographs" of the cartilage between joints and comparing it to engineered versions could lead to better implants, say researchers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!